Solid preparation containing ibuprofen and tranexamic acid
A technology of tranexamic acid and preparation, which can be applied in the directions of anti-inflammatory agent, pill delivery, non-central analgesic agent, etc., can solve the problems of small analgesic effect and the like
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Examples
Embodiment 1
[0058] Example 1 900 g of ibuprofen (manufactured by Yonezawa Hamari: trade name Japanese Pharmacopoeia Ibuprofen), tranexamic acid 1499.4 g (manufactured by Daiichi Sankyo Profile: trade name Japanese Pharmacopoeia Tranexamic Acid), anhydrous citric acid 106.2 g (manufactured by Komatsuya Chemical: brand name Japanese Pharmacopoeia anhydrous citric acid), carmellose calcium 360 g (manufactured by Gotoku Pharmaceutical: brand name ECG505), lactose hydrate 1897.2 g (brand name lactose 200M made by DMV INTERNATIONAL) After throwing into a high-speed stirring granulator (manufactured by Fukae Industry: FS-10 type) and mixing, 466 g of purified water was added and then kneaded. The granulated material was put into a fluidized bed dryer (manufactured by Floint Industries: Model FLO-5) and dried, and then sized by a granulator (manufactured by Okada Seiko: ND-10). 4762.8 g of the whole granules and 97.2 g of magnesium stearate were put into a mixer (manufactured by Kotobuki: PM50 t...
Embodiment 2
[0065] Example 2 Tablets were obtained in the same manner as in Example 1, except that anhydrous citric acid was replaced with malic acid (manufactured by Kawasaki Chemical Industries: trade name malic acid food additive 40M). Test example 2 The tablet obtained in Example 2 was subjected to the same test as in Test Example 1 with the shelf life set at one month. As a result, the expansion ratio after storage at 40° C. for one month was 0.1%, and a remarkable expansion suppressing effect was confirmed. In addition, it was also confirmed that the tablet of the present invention (Example 2) was a stable tablet without cracking or chipping even after storage.
Embodiment 3
[0066] Example 3 Tablets were obtained in the same manner as in Example 1, except that anhydrous citric acid was replaced with propyl gallate (manufactured by Wako Pure Pharmaceutical Industry: trade name propyl gallate).
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com